These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 7601437)

  • 1. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
    Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R
    Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies.
    Barone M; Francavilla A; Polimeno L; Ierardi E; Romanelli D; Berloco P; Di Leo A; Panella C
    Hepatology; 1996 May; 23(5):1159-66. PubMed ID: 8621149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver.
    Benedetti A; Alvaro D; Bassotti C; Gigliozzi A; Ferretti G; La Rosa T; Di Sario A; Baiocchi L; Jezequel AM
    Hepatology; 1997 Jul; 26(1):9-21. PubMed ID: 9214446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver.
    Beuers U; Bilzer M; Chittattu A; Kullak-Ublick GA; Keppler D; Paumgartner G; Dombrowski F
    Hepatology; 2001 May; 33(5):1206-16. PubMed ID: 11343250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: the switch between apoptosis and necrosis.
    Rolo AP; Palmeira CM; Holy JM; Wallace KB
    Toxicol Sci; 2004 May; 79(1):196-204. PubMed ID: 14976352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent mechanism in rat liver.
    Wimmer R; Hohenester S; Pusl T; Denk GU; Rust C; Beuers U
    Gut; 2008 Oct; 57(10):1448-54. PubMed ID: 18583398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis.
    Xiao ZL; Biancani P; Carey MC; Behar J
    Hepatology; 2003 Jun; 37(6):1442-50. PubMed ID: 12774024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of bile acids on cell viability and DNA synthesis by rat hepatocytes in primary culture.
    Martinez-Diez MC; Serrano MA; Monte MJ; Marin JJ
    Biochim Biophys Acta; 2000 Feb; 1500(2):153-60. PubMed ID: 10657584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chenodeoxycholic acid and taurochenodexycholic acid induce anti-apoptotic cIAP-1 expression in human hepatocytes.
    Hirano F; Haneda M; Makino I
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1807-13. PubMed ID: 17074018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes.
    Castro RE; Amaral JD; Solá S; Kren BT; Steer CJ; Rodrigues CM
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G327-34. PubMed ID: 17431217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid.
    Piazza F; Montagnani M; Russo C; Azzaroli F; Aldini R; Roda E; Roda A
    Dig Liver Dis; 2000 May; 32(4):318-28. PubMed ID: 11515630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoprotection with ursodeoxycholic acid: effect in chronic non-cholestatic and chronic cholestatic liver disease.
    Lirussi F; Okolicsanyi L
    Ital J Gastroenterol; 1992 Jan; 24(1):31-5. PubMed ID: 1571577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways.
    Schoemaker MH; Conde de la Rosa L; Buist-Homan M; Vrenken TE; Havinga R; Poelstra K; Haisma HJ; Jansen PL; Moshage H
    Hepatology; 2004 Jun; 39(6):1563-73. PubMed ID: 15185297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis and modulation of cell cycle control by bile acids in human leukemia T cells.
    Fimognari C; Lenzi M; Cantelli-Forti G; Hrelia P
    Ann N Y Acad Sci; 2009 Aug; 1171():264-9. PubMed ID: 19723064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical pharmacology of ursodeoxycholic acid (UDCA)].
    Kryczka W; Grieb P
    Postepy Hig Med Dosw; 1994; 48(1):53-68. PubMed ID: 8058580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TUDCA and UDCA are incorporated into hepatocyte membranes: different sites, but similar effects.
    Leuschner U; Guldutuna S; Bhatti S; Elze A; Imhof M; You T; Zimmer G
    Ital J Gastroenterol; 1995 Sep; 27(7):376-7. PubMed ID: 8563010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
    Qiao L; Yacoub A; Studer E; Gupta S; Pei XY; Grant S; Hylemon PB; Dent P
    Hepatology; 2002 Apr; 35(4):779-89. PubMed ID: 11915023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes.
    Azzaroli F; Mehal W; Soroka CJ; Wang L; Lee J; Crispe IN; Boyer JL
    Hepatology; 2002 Jul; 36(1):49-54. PubMed ID: 12085348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha.
    Alpini G; Baiocchi L; Glaser S; Ueno Y; Marzioni M; Francis H; Phinizy JL; Angelico M; Lesage G
    Hepatology; 2002 May; 35(5):1041-52. PubMed ID: 11981754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
    von Bergmann K; Epple-Gutsfeld M; Leiss O
    Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.